Steve Fesik expands partnership with Boehringer Ingelheim

Posted by daviskd2 on Tuesday, April 3, 2018 in News.

CSB researcher Steve Fesik is launching a new partnership with Boehringer Ingelheim to discover and develop cancer therapies targeting MCL1. This is the third such partnership between the pharmaceutical giant and the Fesik lab. Congratulations!

Read the complete press release here.